Satoshi Kawano

Selective Inhibition of EZH2 by EPZ-6438 Leads to Potent Antitumor Activity in <i>EZH2</i> -Mutant Non-Hodgkin Lymphoma

Sarah K. Knutson, Satoshi Kawano, Yukinori Minoshima et al. · Molecular Cancer Therapeutics · 2014 · 517 citations

Eribulin mesylate reduces tumor microenvironment abnormality by vascular remodeling in preclinical human breast cancer models

Yasuhiro Funahashi, Kiyoshi Okamoto, Yusuke Adachi et al. · Cancer Science · 2014 · 275 citations · Full text

Breast Oncology, Biological Microenvironments, Pathology +19

EPZ011989, A Potent, Orally-Available EZH2 Inhibitor with Robust in Vivo Activity

John E. Campbell, Kevin W. Kuntz, Sarah K. Knutson et al. · ACS Medicinal Chemistry Letters · 2015 · 127 citations · Full text

Pharmacotherapy, A Potent, Ezh2 Activity +17

Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma

Satoshi Kawano, Alexandra Grassian, Masumi Tsuda et al. · PLoS ONE · 2016 · 74 citations · Full text

Molecular Biology, Cancer Biology, Tumor Biology +17

Room temperature epitaxial growth of m-plane GaN on lattice-matched ZnO substrates

Atsushi Kobayashi, Satoshi Kawano, Yuji Kawaguchi et al. · Applied Physics Letters · 2007 · 73 citations · Full text

Materials Engineering, Materials Science, Electrical Engineering +13